01
Fractional Sales Force & Market Access
A battle-tested commercial execution team embedded directly into your go-to-market strategy. Senior executives with established relationships across every critical healthcare buying center — ready to move immediately.
- Fractional VP of Sales & Strategic Account Directors
- IDN, hospital system, and health system penetration
- GPO contract navigation and pull-through execution
- Specialty practice and physician group access
- Payer and market access stakeholder engagement
- Aesthetic, med spa, and cash-pay channel development
- Vitreoretinal and ophthalmology specialty access
- Ambulatory surgery center and outpatient clinic coverage
- Revenue-accountable performance structure
For: 503A · 503B · Pharma Manufacturers
02
FDA Readiness & Compliance Auditing
Proactive compliance positioning is not optional — it is a competitive advantage. Vendxa's FDA readiness audits are designed to identify vulnerabilities before regulators do, protecting your operational license to compete and instilling confidence with institutional customers.
- 503B outsourcing facility readiness assessments
- Gap analysis against current FDA guidance frameworks
- cGMP compliance and documentation review
- DSCSA traceability and supply chain protocol auditing
- Sterile compounding and quality system evaluation
- State board and federal regulatory alignment
- Pre-inspection preparation and mock audit facilitation
- Corrective action planning and executive reporting
- Ongoing compliance monitoring programs
For: 503B Outsourcing Facilities · 503A Organizations
03
Advisory Boards & New Product Intelligence
The most powerful question in commercial strategy is: what do your customers actually need? Vendxa curates and facilitates high-impact advisory boards that connect your product development pipeline with the clinical and operational reality of prescribers, pharmacists, and institutional buyers.
- Advisory board curation, assembly, and facilitation
- KOL identification across therapeutic specialties
- Unmet clinical need gap analysis and market mapping
- New product opportunity identification for compounders
- Formulary intelligence and procurement preference research
- Clinical feedback integration into product development
- Competitive landscape and pipeline benchmarking
- Executive stakeholder reporting and strategic summaries
- Ongoing advisory network management
For: 503A · 503B · Pharma Manufacturers